Abstract:Gallic acid is a plant-derived phenolic compound with various medicinal values, including antioxidant properties. The primary method for producing gallic acid at present involves the chemical or enzymatic hydrolysis of tannins extracted from plants, which is associated with high costs and serious environmental pollution. Green synthesis based on microbial cell factories offers an effective alternative route for the production of gallic acid. However, the current yields of green synthesis are insufficient for industrial-scale requirements. Therefore, the development of a de novo synthesis strategy for gallic acid using low-cost substrates holds significant potential for industrial applications. In this study, an Escherichia coli strain capable of efficiently synthesizing 3-dehydroshikimic acid was used as the chassis organism. Initially, the key enzymes for the optimal synthesis pathway of gallic acid were identified as 3-dehydroshikimate dehydratase (AroZ) and 4-hydroxybenzoate hydroxylase (PobA), with an optimal expression ratio of 1:20. The optimal pathway was constructed within the chassis strain through plasmid copy number and promoter engineering. Protein engineering was further employed to obtain a mutant of the rate-limiting enzyme, PobAM2/A45S/V47P, which enhanced the shake flask production level of gallic acid to 3.6 g/L. Finally, strain stability and fermentation condition optimization were conducted in a 5 L fermentor, resulting in a gallic acid yield of 26.7 g/L and a sugar-to-acid conversion rate of 0.15 g/g. This study achieves a breakthrough in the de novo synthesis of gallic acid from glucose, providing an important reference for enhancing the biological synthesis of gallic acid and related phenolic acids from plants.